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Lung diseases, cancers, and trauma can result in injury to the connective tissue 
lining the lung, i.e., the pleura. Pleural injuries lead to pneumothoraxes or pleural 
effusions, i.e., air or fluid leaking out of the lung respectively, and potential lung collapse 
- an immediately life threatening condition. While several bioengineered soft tissue 
sealants exist on the market, there is only one sealant FDA-approved for use in 
pulmonary surgery. In addition, very limited techniques are presented in the literature for 
characterizing the burst properties of hydrogel tissue sealants. For my thesis, I proposed 
to develop a protocol for characterizing the burst properties of hydrogel sealants using a 
novel burst pressure test chamber. I further proposed a novel combination of oxidation 
and methacrylation reactions of alginate for tissue sealant applications, with a particular 
focus on developing a pulmonary sealant. The proposed research objectives are: 1) To 
develop protocol for testing hydrogel sealants for soft tissue applications; 2) To verify 
alginate as a potential for tissue sealant applications; and 3) To optimize an alginate 
hydrogel sealant and perform ex vivo analysis for a pleural sealant application. Alginate 
materials with varying degrees of oxidation and methacrylation were synthesized and 
characterized. Oscillatory rheometry was used to characterize material properties such as 
viscosity, hydrogel gelation kinetics, and complex moduli. Burst pressure measurements 
properties and failure mechanisms, i.e. delamination or material failure, were collected 
for a liquid and dry-state application. Preliminary ex vivo mouse lung model testing 
demonstrated that methacrylated alginate hydrogels are able to withstand physiological 
pressures associated with breathing, and failure occurs within the hydrogel for adhesive 
alginate-based tissue sealants.  
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 CHAPTER 1: MOTIVATION 
1.1. Introduction 
The lungs are a complex system of airways and alveoli, which permit for the gas 
exchange vital to life. The average person breathes 12-20 breathes per minute, which 
equates to roughly 21,000 cyclic loads per day or 550,000,000 cyclic loads over the life 
of the lungs.1 During respiration, the diaphragm muscles helps expand the chest cavity, 
causing a pressure difference in the cavity and allowing for air flow into and expansion of 
the lungs.2  As with any system that sees repeated cyclic loading within a confined space, 
minimized friction is critical for optimal function. This is accomplished in the chest 
cavity via the visceral and parietal pleurae, which line the surfaces of the lung and chest 
cavity respectively.2 These pleurae secrete small amounts of pleural fluid, which forms a 
slippery coating between the thoracic cavity and the lungs, providing lubrication during 
respiration.2  The pleura are also responsible for preventing fluids, such as air, lung 
surfactant, mucus, etc., from leaking out of the lungs and into the pleural cavity 
surrounding the lungs.3  
Figure 1. Simplified schematic showing lungs and pleurae within the chest 
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 Each year, over one million people develop diseases which result in air 
(pneumothorax) or liquid (pleural effusions) leaking out of the lung and into the pleural 
space.4 These pleural diseases can be the result of a variety of diseases, such as 
congestive heart failure, pneumonia, and lung cancer, or of physical trauma to the lung, 
such as a puncture or tear.4 The resulting lung collapse can be immediately life 
threatening and requires immediate intervention. A thoracentesis must be performed to 
remove the trapped fluid and allow for the lung to expand.5 This is done by placing a 
needle or tube in the pleural cavity to drain out the air or liquid. Depending on the cause 
of the leak, chronic leaking, also known as a bronchopleural fistula, may occur and 
repeated chest tube drainage may be necessary.6, 7  
  Several different methods have been developed to treat these chronic injuries in 
the lung pleura. These methods include pleurodesis (chemical or physical),8-13 natural14-25 
and synthetic polymer sealants.26-38 These treatments vary in physical characteristics and 
mechanical properties, which alters efficacy, duration of treatment, and invasiveness as 
pulmonary sealants.  
Figure 2: Cartoon schematic of proposed study 
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1.2. Goal of Study 
 Engineered tissue adhesives and surgical sealants are becoming more prevalent 
in surgical suites as current medical and robotic technologies improve, simplifying the 
procedures of complex internal surgeries. As these technologies advance, conventional 
methods of sealing tissues, such as staples and sutures, become more cumbersome and 
time-consuming.39 Currently there are very few effective treatments for persistent 
pneumothoraxes and pleural effusions and only one FDA-approved pulmonary surgical 
sealant to prevent recurring leaks as the underlying tissue is repaired. The overall goal of 
this study is to investigate the potential use of alginate, an algae-derived biopolymer, as a 
surgical sealant in pulmonary applications. Various chemical modifications will be 
addressed for modifying the mechanical properties of alginate to serve as an artificial 
pleura biomaterial. Alginate hydrogel solutions will be mechanically characterized 
through oscillatory rheology. Protocols will be developed for characterizing the burst 
properties of the resultant alginate hydrogels on a custom-fabricated burst pressure 
device, modified from ASTM F2392-04R10, the standard test method for burst strength 
of surgical sealants.40 Finally, ex vivo mouse model testing will be performed to test the 
efficacy of the alginate material as a pulmonary sealant. 
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CHAPTER 2: Background and Literature Review 
2.1. Pleurodesis 
In the 1990’s pleurodesis thoracostomy was the current, and most commonly 
practiced treatment for pneumothorax and pleural effusion to prevent further leakage into 
the pleural cavity after the initial removal of fluid.11 “The aim of pleurodesis is to achieve 
a symphysis between visceral and parietal pleural layers, in order to prevent 
accumulation of either air or fluid in the pleural space”. 12 Physical pleurodesis is a 
surgical technique involving suturing or pleural abrasion procedures through the use of 
thoracotomy, which involves creating an incision into the pleural space and using 
advanced video-assisted thoracic surgery (VATS). VATS enables a small video camera 
to be put into the chest cavity, giving the surgeon more visibility during surgery and 
allowing for a much safer procedure.13 Once inside the chest cavity, the hole can be 
sutured shut via a staple or pleural abrasion can be done. Pleural abrasion involves 
irritating the parietal pleura using a domestic nylon scouring pad or gauze. Due to this 
inflammation, the visceral and parietal pleurae become adhered to each other, sealing the 
leak site.9 Chan et al studied 88 video-assisted thoracoscopic pleurodesis surgeries from 
1992 to 1998, where the parietal pleura was abraded with a piece of Marlex mesh scratch 
pad.41 Of those 88 there were only five recurrences (5.7%).13 With most patients under 
general anesthesia the pain levels remained fairly low, 64 cases reported a 0 pain level 
(72.7%).13  
  Chemical pleurodesis consists of applying a chemical solution on the lung wall 
via a chest tube to cultivate an inflammatory response, adhering the pleurae and 
preventing leakage. Several different chemicals have been used to induce this 
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inflammation based on availability, cost, efficiency, effectiveness and safety.11 A 
concentrated tetracycline solution, which causes an effective seal, was commonly used in 
early trials of chemical pleurodesis.8  Parenteral tetracycline, however, is no longer 
commercially available in the U.S. due to a shortage, which led to a search for a 
substitute.10, 11 Currently doxycycline, bleomycin, and talc remain as reliable and 
generally effective chemical agents and are of the most commonly used. 11Doxycycline 
was an immediate replacement for Tetracycline, but was quickly replaced since multiple 
treatments were required for effectiveness, which is less than optimal.11 Bleomycin, an 
antibiotic that binds DNA producing breakage and inhibits DNA synthesis, was shown to 
be much more efficient, requiring less treatments than that of doxycycline.11 Bleomycin 
is widely used because of its efficiency and sclerosing properties for pleurodesis, 
however, some patients experience fatal alveolar injury due to the toxicity of the drug.11 
Zimmer et al. shows that bleomycin reduces pain and difficulty of breathing (dyspnea) 
but the overall success rate of treatment still remains around 70%.11 Talc, a tri-layered 
magnesium sheet silicate that is readily available, efficient, and cost effective, is more 
commonly preferred in today’s treatments because of a high success rate.10 Talc is 
applied either using a dry heat exposure as a poudrage (powder or dusting) or as a slurry 
via thoracostomy. Both methods and compositions are effective in the control of 
malignant pleural effusion.11  Not only does talc have high success rates, but the patient’s 
difficulty breathing or dyspnea reduces the most compared with previous chemical 
treatments. Although chemical pleurodesis has proven to have high success rates, the 
procedure is intrusive and may have many negative short term effects, including fever, 
pain, infection, and respiratory failure.10 
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2.2. Natural Polymeric Tissue Sealant Approaches 
Hydrogels have been used in a widening variety of biomedical applications. Due 
to their tunable mechanical properties through polymeric chemistry, much interest has 
been shown in developing specialized hydrogel biomaterials for specific clinical use. 
While the application of hydrogels as surgical sealants and wound treatment began 
developing in the 1960’s, the use of hydrogels to treat pulmonary air leaks began in 
earnest in the late 1980’s14. Early hydrogels used for pulmonary seals were composed of 
naturally-derived polymers (collagen, fibrin), but many other naturally- and synthetically-
derived polymers have been investigated for surgical sealant applications as our 
understanding of hydrogels increases.15, 16 
Starting in the late 1990’s, fibrin began to be studied as a natural-based polymer 
sealant. Fibrin sealant is a haemostatic and wound support product consisting of blood 
coagulation factors fibrinogen, factor XIII, thrombin, aprotinin and calcium chloride. 
This mixture gives rise to the formation of a stable, cross-linked fibrin clot. Granulation 
tissue, new vascular tissue on the healing surface of a wound, can be seen 3 days after 
implementation and proliferation of collagen fibers after 4-7 days.17 Studies have shown 
that the clotting time is dependent on the concentration of thrombin in the sealant. For 
thoracic and vascular surgical procedures it is common practice to perform suturing prior 
to applying the fibrin solution. In a single-blind study, i.e. a study where the researcher 
but not the subjects know the makeup of test and control groups, comparing suturing and 
suturing with fibrin sealant, the length of stay in the hospital was one day less in patients 
who received treatment for a variety of anastomoses with fibrin sealant than those who 
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did not. A reduction in the incidence of pulmonary (or bronchopleural) air leakage of 
41% was associated with the use of fibrin sealant.17 In 2002, Fabian et al. discovered a 
better application method for surgical applications using an aerosolized fibrin glue rather 
than the topical application. In a randomized, single-blind study, Fabian et al. discovered 
a 50% reduction of alveolar air leaks after pulmonary resection with the use of 
aerosolized fibrin glue (HemaMyst® System) and standard stapling procedures compared 
to just standard stapling procedures.18 The preparation of glue components only requires 
roughly 5 minutes and another minute to apply the glue. Best of all it is relatively 
inexpensive ranging from $70 and $90 per cc.18 The fibrin glue Tisseel®, is FDA 
approved and is used in many applications.19 Despite this, fibrin glue has failed to 
demonstrate efficacy for pulmonary applications in several small clinical trials.18 
 Another sealant that is being used is chitosan, which is derived from chitin. 
Chitosan has many application is due to its biocompatibility, low toxicity, structure 
similarity to glycosaminoglycan’s, and its ability to degrade with certain enzymes.16 Ono 
et al. reported a bursting pressure of 51± 11 mmHg (69±15 cmH2O).20 This study 
suggests that modified chitosan can form a more effective seal in aortic, tracheal, and 
pulmonary applications, but is still being researched. 
There are a few applications of multiple sealants being used. TachoComb®, 
discovered by Matsutani et al., is a fibrin-glue coated collagen fleece that is able to 
conform in shape to the pleural defect that it is applied to and withstand high pressures 
(greater than 40 cmH2O). TachoComb® is combined with overlapping the defect with the 
surrounding normal pleural tissue.21 An issue with TachoComb®  is when applying the 
material to a pleural defect it is difficult to keep it free of blood/fluid interaction 
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before implementing to the site. When the material comes in contact with blood it almost 
instantly becomes very sticky and difficult to manipulate. Nakajima et al. discovered an 
innovative design to deliver the TachoComb®  via a rubber tube, then conveying it into 
the application site and applying it using standard laparoscopic forceps.22 This allows the 
TachoComb®  to remain free of blood/fluid before it reaches its destination and allows 
TachoComb®  to be used in minimally invasive surgery. TachoComb®  did not receive 
FDA approval due to the use of bovine thrombin and aprotinin. 
One concern with fibrin is how it can possibly transmit blood-borne diseases. 
With this concern in mind, a new product has evolved called Integran.  Integran is a sheet 
type absorbable topical collagen hemostat which contains no blood-derived products. On 
average Integran cut the number of air leaks by a third after application compared to 
TachoComb® .23  
Another natural polymer-based sealant involves the reaction of bovine serum 
albumin (BSA) and glutaraldehyde, which covalently bond to form a flexible seal upon 
mixing.24, 25 This reaction is used in the commercially available BioGlue®. The BSA and 
glutaraldehyde solutions come in a dual syringe applicator, which mixes the solution as 
they are applied. The FDA reported that BioGlue® grafts withheld pressures of 300 
mmHg.26 This far exceeds the normal physiological pulmonary pressure associated with 
respiration of 30 cmH2O.
1, 3 
 
2.3. Synthetic Polymeric Tissue Sealant Approaches 
Due to its biocompatibility, low toxicity, and FDA approval, poly(ethylene 
glycol) (PEG), also known as poly(ethylene oxide) (PEO) or poly(oxyethylene) (POE) 
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depending on the molecular weight, is the primary synthetic polymer used in repairing 
pulmonary and alveolar air leaks, although there is interest in a surgical sealant based on 
poly(lactic-co-glycolic acid) (PLGA).16, 27-31 One of the first PEG-based pulmonary seals 
utilized a two-solution (primer-sealant) method with acrylate-capped poly(L-lactide) and 
poly(trimethylene carbonate) and a photoinitator, Eosin-Y, to form a sealant.32-34 Upon 
exposure of the photoinitiator to blue-green light, the primer and sealant polymerize to 
form a crosslinked, flexible hydrogel network.33, 42 Macchiarini et al. reported a 
polymerization time of 40 seconds.32 While this sealant is able to withstand pressures 
exceeding peak pulmonary pressure, the application method requires intraoperative 
photoinitation, which can be complicated.34 This PEG- based sealant is commercially 
available in Europe and Canada as FocalSeal® and was approved by the FDA in 2000. 
To avoid photoinitation, several two-solution, PEG-based surgical sealants were 
developed which begin to polymerize after the two solutions are mixed.28, 35, 41 The earlier 
of these sealants consisted of two basic components: PEG disuccinimidyl succinate 
(PEG-SS2), a PEG derivative, and human serum albumin (HSA), a protein naturally 
produced by the liver.28 The two solutions are mixed at the time of use and delivered 
through a specialized dual-syringe system. Kobayashi et al. reported rapid chemical 
crosslinking between the PEG-SS2 and HSA, forming a hydrogel within 15 seconds that 
can withstand twice normal peak pulmonary pressure.28 A major drawback to this 
hydrogel is that HSA is derived from blood plasma, which presents control and disease 
problems. Commercially available Progel® utilizes this PEG-SS2 HSA chemistry. A 
second PEG-based, two solution sealant consists of dilute PEG- hydrogen chloride and 
PEG- sodium phosphate/sodium carbonate solutions, which come in a preassembled, dual 
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syringe applicator36. Campbell et al. reported a polymerization time of less than three 
seconds after mixing, while Wallace et al. reported a burst strength five times greater than 
peak pulmonary pressure.29, 36 This dual PEG-based-solution treatment is available in 
Europe, but not the United States, commercially as CoSeal®. A third two-solution 
surgical sealant utilizes PEG and trilysine, an essential amino acid, to form a hydrogel. 
Similar to CoSeal® and Progel® , the PEG and trilysine solutions are mixed upon 
application and crosslink within seconds to form a flexible hydrogel.35 Pederson et al. 
reported a median bursting strength of 35 cmH2O, which is ablove normal PPP. This 
technology was introduced as a surgical sealant in Europe as PleuraSeal®, but never 
obtained FDA approval and later underwent a voluntary recall. 
 A final synthetic polymer sealant currently being tested as a surgical sealant 
contrasts with the previously mentioned sealants due to a lack of liquid application, 
greatly decreasing the difficulty of application.31 This patch sealant is composed of 
PLGA-Poly(VP-AAc-AAc(NHS)) and adheres to the lung after application under 
moderate pressure through rapidly formed amide bonds.37 Shea reported a bursting 
strength of 140.6±58.2 cmH2O.38  
 
2.4 Alginate 
 Alginate is a naturally-derived polysaccharide polymer composed of repeating 
(1,4)-linked β-D-mannuronate (M) and α-L-guluronate (G) mers.43 (Figure 2Figure 3) 
Alginate, derived from brown alga, is a popular polymer in the food, cosmetic, and 
bioengineering fields due to its low-cost, abundant source, and biocompatible nature.16, 43, 
44 As such, there are many commercially available alginates with a wide range of 
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characteristics and mechanical properties for use in varying applications. Alginate is 
popular among bioengineers due to its highly tunable physical properties and various 
crosslinking methods.44-48 Composition, block length, and molecular weight are three 
characteristics which, when altered, will drastically change the mechanical properties of 
the resulting alginate hydrogel.43 Alginate derived from various brown algae will have 
varying compositions of mannuronate and guluronate building blocks, which affects the 
overall structure of the polymer. The repetition of these building blocks to form 
consecutive G residues, consecutive M residues, and alternating M-G residues, and the 
length of these residues, also greatly affects the properties of these polymers in different 
applications.43 For example, guluronate blocks drive intermolecular cross-linking via 
divalent cations. Increasing molecular weight changes the physical propertes of the 
resulting gel, i.e. increased loading, stiffness, and moduli, while also increasing viscosity. 
Longer chains are able to entangle and interact more readily than shorter chains, leading 
to these increased properties.  Addition of functional side groups and modifications to the 
alginate backbone also provides an opportunity to tune properties for specific 
applications.47, 48 These chemical modifications also allows alginate to be crosslinked in a 
variety of manners. Typically alginate can be ionically crosslinked, however the addition 
of functional side groups can allow for covalent, thermal, and improved physical 
crosslinking. The research presented below is based on Manugel GMB alginate (FMC 
Biopolymer), which has a high G block content and relatively high molecular weight (80-
120 kDa). Manugel GMB was chosen because the high G:M ratio allows for effective 
ionic crosslinking via a calcium chloride reaction and the high molecular weight will 




2.4.1 Alginate Chemistry 
 Several groups have investigated chemical modification of alginate for a variety 
of bioengineering applications.43, 45, 47 Jeon et al. reported methacrylating alginate via 1-
ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride and N-
hydroxysuccinimide, resulting in a photocrosslinkable alginate for therapeutic 
materials.47 Skardal et al. reported a means of methacrylating hyaluronan, another 
commonly used polysaccharide biopolymer, utilizing methacrylic anhydride in deionized 
water.49 Lee et al. also explored other means of crosslinking alginate. This group was 
able to covalently crosslink alginate with poly(ethylene glycol)-diamines.43  Besides 
Figure 3: Top- Chemical structure of alginate repeat units; Bottom- alginate chain 
depicting short G-G,  M-M, and M-G residues 
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these means of covalently crosslinking alginate, there are several other means for alginate 
gelation, such as thermal cross-linking, though these means fall outside the scope of this 
study.43 Another chemical modification that has been explored in alginate chemistry is 
oxidation. Several groups have used oxidation as a means of controlling the degradation 
properties, i.e. rate of degradation, particle size, etc., of alginate.46, 48 Gomez et al. and 
Jeon et al. both present slightly varying methods of oxidation via sodium periodate, 
though many oxidizing agents exist. As this method seemed compatible with alginate, 
sodium periodate oxidation was chosen as the desired method.  
 
2.5 Mechanical Testing of Tissue Sealants and Adhesives 
 A literature review results in few cases of mechanical burst pressure testing of 
soft hydrogel sealants. The American Society for Testing and Materials (ASTM) is the 
best source of information on testing procedures for a wide range of materials. ASTM 
F2392 Standard Test Method for Burst Strength of Surgical Sealants provided the basic 
design for a burst pressure device.40 The protocol didn’t allow for testing of hydrogel 
sealants with in situ photocrosslinking and was modified accordingly. Several other 
standards provided information on collecting adhesive strength, but the load application 
didn’t reflect pulmonary conditions and were not pursued.50-52 
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CHAPTER 3: ALGINATE CHEMISTRY 
3.1. Introduction 
As was mentioned above, the mechanical and physical properties of alginate can 
be changed via chemical modification. This can be done through the addition of 
functional side groups or by modifying the backbone of the alginate itself. Care must be 
taken when modifying any polymer, as the chemical modifications can have unintended 
repercussions, such as chain scission. This study focuses on the addition of a functional 
methacrylate side group and open-chain adduct conformation to tune properties for a 
pulmonary sealant application. 
3.2. Methacrylation Chemistry 
 In order to form an effective pulmonary hydrogel sealant, a safe and effective 
means of crosslinking alginate into a hydrogel must first be addressed. Commercially 
available sodium alginate can be crosslinked to form a hydrogel upon exposure to 
calcium chloride, forming ionic bonds between the alginate chains. Unfortunately, the 
resulting hydrogel is relatively weak, as the ionic bonds can be easily broken, and stiff, 
not allowing the sealant to flex with the lung. Alternatively, the addition of functional 
methacrylate side groups onto the alginate backbone allows for covalent bonding 
between chains, forming a more durable hydrogel. Several methods have been developed 
in order to methacrylate alginate to varying degrees. Control over the reaction is 
paramount, as the degree of methacrylation will influence the final properties of the 
hydrogel. 
 
3.2.1. Aqueous Method 
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 The first method investigated as a means of methacrylation was an aqueous-
based reaction utilizing methacrylic anhydride (Sigma Aldrich). A 20-molar excess of 
methacrylic anhydride is added to a 1% (w/v) sodium alginate solution.49 (Figure 4) The 
resulting solution is treated with sodium hydroxide to maintain a solution pH of 8.5 and 
allowed to stir for 12 hours. The solution is then further treated with sodium hydroxide to 
a pH of 7.0 and dialyzed with deionized water for 3 days, adjusting the pH periodically. 
The final solution is lyophilized and stored until testing and characterization. Since 
methacrylic anhydride is poorly soluble in water, a 20-molar excess is required to ensure 
the reaction occurs. This poor solubility and molar excess limits control over the 
methacrylation reaction and therefore alginate methacrylated in this manner has a 
theoretical modification of 100%, though full modification is seldom obtained. Sodium 
alginate can be replaced with oxidized sodium alginate if oxidized methacrylated alginate 
is desired. Proton nuclear magnetic resonance spectroscopy was utilized to determine the 
degree of methacrylation, or ratio of methacrylate groups per repeat unit of alginate. This 
was accomplished by calculating ratios of relative integrations of the methacrylate peaks 
and alginate methyl proton. 
Figure 4: Chemical synthesis of methacrylated sodium alginate via aqueous chemistry. 
Methacrylation can occur at any of the hydroxide sites on any uronate ring. 
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3.2.2. Anhydrous Method 
 The second method investigated for methacrylation was a novel reaction 
utilizing anhydrous dimethyl sulfoxide (DMSO, Sigma Aldrich) and methacrylic 
anhydride. Since methacrylic anhydride is more readily soluble in dimethyl sulfosxide, a 
high molar excess is not required to ensure a proper methacrylation, allowing for more 
control over the reaction. While sodium alginate is soluble in water, it is not readily 
soluble in DMSO. In order to increase the solubility, an ion exchange is performed, 
replacing the sodium ion with a dodecyltrimethylammonium ion. (Figure 5) This can be 
accomplished by gradually mixing a 1% (w/v) alginate polymer solution in deionized 
water with an equal volume of a 2-3% solution of dodecyltrimethylammonium bromide 
(DTAB, Sigma Aldrich) in deionized water. Upon mixing, the sodium ion on the alginate 
backbone reacts with the bromide ion in the DTAB, forming sodium bromide. The 
remaining dodecyltrimethylammonium ions bind with the alginate backbone, forming a 
compound that is insoluble in water, and falls out of the solution as a precipitate. The 
supernatant (sodium bromide solution in deionized water) can be removed and the 
remaining precipitate can be rinsed in deionized water several times and lyophilized. The 
resulting dodecyltrimethylammonium alginate (Alg-DTA) polymer can be readily 
solubilized in DMSO for the methacrylation reaction. For methacrylation, an Alg-DTA 
solution in DMSO must be prepared under nitrogen gas flow to prevent any moisture in 
the air from disrupting the reaction, with a final 1% (w/v) concentration of alginate. Next, 
a 1:2 molar ratio of 4-dimethylaminopyridine (DMAP, Sigma Aldrich) to Alg-DTA is 
added to the solution. The DMAP acts as a catalyst and allows for full modification with 
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a lower molar excess.  For a theoretical 100% modification, a 4:1 molar ratio of 
methacrylic anhydride to alginate is added under nitrogen flow and stirred overnight. 
Altering the molar ratio of methacrylic anhydride to alginate allows for greater control 
over the degree of methacrylation. After stirring, a molar equivalent of hydrochloric acid 
is added to neutralize any remaining DMAP. This solution is dialyzed against deionized 
water 1 day, followed by a 3 day dialysis against 0.8M sodium dibasic phosphate and a 
further 3 day dialysis against deionized water. During the first dialysis, the resulting 
methacrylated Alg-DTA polymer falls out of solution as the DMSO is replaced with the 
less solubilizing deionized water. Dialyzing against 0.8M sodium dibasic phosphate 
drives another ion exchance, replacing the dodecyltrimethylammonium ion with a sodium 
ion. This enables the methacrylated alginate polymer’s solubility in water. The final 
dialysis in deionized water removes any excess sodium ions from the polymer. The 
polymer solution pH is periodically adjusted to 7.0. This final solution can be lyophilized 
to a dry form. Sodium alginate can be replaced with oxidized sodium alginate if oxidized 
methacrylated alginate is desired. Specifying the degree of methacrylation is desirable 
because altering the degree of methacrylation changes the structure of the resulting 
hydrogel network, directly impacting the mechanical properties of the hydrogel. For 
example, a lower degree of methacrylation would result in a less crosslinked network that 
may exhibit enhanced flexibility, allowing the hydrogel sealant to conform to the lung 
surface during respiration. Materials with high and low degrees of methacrylation will be 
prepared to see the effects on the resultant hydrogel. Proton nuclear magnetic resonance 
spectroscopy was utilized to determine the degree of methacrylation, or ratio of 
methacrylate groups per repeat unit of alginate. This was accomplished by calculating 
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ratios of relative integrations of the methacrylate peaks and alginate methyl proton. 
 
 
3.3. Oxidation Chemistry 
 Besides providing an effective sealing barrier, any pulmonary sealant must also 
adhere to the lung surface and remain in place during respiration. Initial studies of 
methacrylated alginate indicated an effective, if brief, sealing of puncture lung tissue 
before patch delamination, i.e. separation from the lung surface without bursting. 
Alginate inherently lacks cell adhesivity, explaining the cause of delamination and 
presenting a new challenge to address. While there are many methods to promote cell and 
tissue adhesion, one of the simplest methods is oxidation chemistry. Sodium periodate 
(Sigma Aldrich) oxidation alters the conformation of the uronate residues to an open-
chain adduct (Figure 66), increasing the valence of the residue and allowing for improved 
Figure 5: Chemical synthesis of methacrylated sodium alginate via Anhydrous chemistry. 
Methacrylation can occur at any of the hydroxide sites on any uronate ring. 
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interaction with proteins, such as collagen, in the lung tissue.45, 48 For the oxidation 
reaction, 1-2% (w/v) alginate and 2-5% (w/v) sodium periodate solutions are prepared in 
deionized water in separate vessels.  To achieve a theoretical full oxidation, a 1:1 mass 
ratio of alginate to sodium periodate is used. Altering this ratio allows for control over the 
degree of oxidation. The solutions are then mixed and allowed to stir for 24 hours at 
room temperature in a dark environment. The resulting oxidized sodium alginate solution 
is dialyzed against deionized water for 3 days and lyophilized to a dry form. Sodium 
alginate can be replaced with methacrylated sodium alginate if oxidized methacrylated 
alginate is desired. The oxidation reaction alters the structure of the uronate rings, 
preventing methacrylation of the hydroxide group formerly at that site. Proton nuclear 
magnetic resonance spectroscopy was utilized to determine the degree of methacrylation, 
or ratio of methacrylate groups per repeat unit of alginate. This was accomplished by 
calculating ratios of relative integrations alginate methyl proton and first methylene 
proton.48 
 
Figure 6: Chemical synthesis of oxidized sodium alginate via sodium periodate oxidation chemistry. 
Oxidation reaction can alter the uronate ring for either guluronate or mannuronate. 
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CHAPTER 4: RHEOLOGICAL CHARACTERIZATION 
4.1. Introduction 
After chemical modification, the first step to understanding the characteristics and 
mechanical properties of the hydrogel precursors is through rheological testing. Rheology 
is often used to characterize the deformation and loading characteristics of non-
Newtonian fluids, such as polymer solutions. All measurements were carried out on a 
rheometer (AR2000, TA Instruments) equipped with a Peltier cone-and-plate geometry 
(40-mm diameter, 1°59′47″, hard anodized aluminum) maintained at 25°C  
 
4.2. Viscosity and Shear Stress 
 Chemical modification of alginate may result in degradation, i.e. chain scission, 
and reduction in the molecular weight of the alginate backbone, depending on the nature 
of the chemical reaction. It has been documented that methacrylation chemistry can be 
damaging to the alginate backbone and oxidation reactions have been used to partially 
degrade polymers in various applications, thus changes in the polymer structure are 
expected as a result of the modifications.43, 48 These structural changes result in materials 
with varying mechanical properties, which were examined via rheology. Viscosity (Pa s) 
and shear stress (Pa) of the polymer solutions were measured at varied shear rates, 1-100 
(1/s), at 1% radial strain over one minute and analyzed using analytical software (TA 
Data Analysis). The effect of shear rate on viscosity and shear stress values of 3% (w/v) 
solutions is depicted below. (Figure 77) A 3% solution was chosen as it allows for 
collection of reliable data while minimizing polymer use. Solution viscosities decreased 
exponentially with increasing shear rates for all solutions tested. Compared to non-
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modified alginate solutions, the aqueous methacrylated alginate (Alg-MA) solution 
maintained relatively high viscosities and shear stresses. In contrast the methacrylated 
and oxidized alginate (Alg-MA-Ox) solutions exhibited greatly reduced viscosities and 
shear stresses when compared to alginate and Alg-MA solutions. This indicates the 
oxidation reaction resulted in degradation, or chain scission, of the polymer backbone, 
decreasing its stiffness, moduli, and viscosity. While both the 10 and 30 DOO Alg-MA-
Ox were degraded, the 10 DOO sample had a slightly higher viscosity, indicating 
increasing DOO increases degradation of the polymer backbone. 
 
To form an effective seal, a liquid tissue sealant must portray a viscosity suitable 
to maintain a film over the defect during the curing process. While oxidation is required 
to maintain adhesion to the pulmonary tissue, the necessary amount or degree of 
oxidation has not been fully studied. Therefore, Alg-MA was blended with Alg-MA-Ox 
to preserve the viscosity and material properties, while maintaining theoretical adhesion. 
Alg-MA and Alg-MA-Ox blends (1:1) were created from the same aqueous 
Figure 7: Rheological experiments were performed on 3% (w/v) Alg-MA and Alg-MA-Ox solutions 
and (1:1) blends of Alg-MA and Alg-MA-Ox. (A) Viscosity vs. shear rate plots and (B) shear stress 
vs. shear rate plots are shown, average values are reported. Aqueous methacrylation method. 
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formulation of Alg-MA and Alg-Ox-MA with varying degrees of oxidation (10, 30, and 
50%). (Figure 7) The viscosity and shear stress values for the blended solutions lie 
between respective component values and were similar, indicating that the properties of 
the Alg-MA polymer are dominant for viscosity and shear stress.  
 
 The effect of shear rate on viscosity for the latest generation of materials, those 
oxidized and then methacrylated (Alg-Ox-MA) via the anhydrous method, are depicted 
above. (Figure 88) Alginate was oxidized first to study an earlier hypothesis that 
oxidation prior to methacrylation would result in a hydrogel with greater elasticity. 
Alginate was oxidized to varying degrees (10, 30, or 50%) and subsequently 
methacrylated to varying degrees (15 or 30%). Unfortunately, the 30 and 50 DOO 
alginates proved too degraded for testing. This provided initial indication that oxidation 
prior to methacrylation may result in a further degraded polymer. Unmodified alginate 
was also methacrylated as a control. 3% (w/v) solutions of 15 DOM, 30 DOM, blended 
(1:1) 10 DOO 15 DOM: 15 DOM, blended (1:1) 10 DOO 30 DOM: 30 DOM, blended 
Figure 8: Rheological experiments were performed on 3% (w/v) Alg-MA, (1:1) blends of Alg-Ox-MA 
and Alg-MA, and (1:1) blends of Alg-Ox and Alg-MA. Viscosity vs. shear rate average values are 
reported. Anhydrous methacrylation utilized. 
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(1:1) 10 DOO: 15 DOM, and blended (1:1) 10 DOO: 30 DOM were formed and fully 
characterized. Solution viscosities decreased exponentially with increasing shear rates for 
all solutions tested. Methacrylated alginates solution viscosity was relatively higher than 
the blended solution viscosities, indicating polymer degradation due to the oxidation. 
Solution viscosity also dropped due to the methacrylation reaction, evident by the 
decreased viscosity for the 30 DOM solution compared to the 15 DOM material. Both 
values were considerably lower than the solutions prepared via the aqueous method, 
indicating the anhydrous reaction may be harmful to the polymer backbone.  
4.3. Photocrosslinking and Gelation 
Oscillatory time sweeps were conducted at 10% radial strain and 1 Hz during 
exposure to green light (525 nm, custom 37/8 inch diameter LED ring, NFLS-G30X3-
WHT, SuperbrightLEDs) over a period of 10 minutes (600 seconds). Data collection was 
initiated upon the start of light exposure. Shear storage (G′) and loss (G″) moduli were 
recorded; tan delta (ratio of G″ to G′) was analyzed using analytical software (TA Data 
Analysis). The gelation of Alg-MA and Alg-Ox-MA hydrogels was examined after shear 
sweep experiments. Aqueous Alg-MA and Alg-Ox-MA solutions, in the presence of 
photoinitiators, were crosslinked and formed into hydrogels upon exposure to green light. 
Eosin Y in 1-vinyl-2-pyrrolidinone was used as photosensitizer and catalyst, while 
triethanolamine served as an electron donor.53-57 The gelation times of the hydrogel 
solutions were determined from oscillatory time sweep plots. (Figure 9 and Figure 10) 
The initiation of gelation, i.e., gelation time, was determined to be at the inflection point 
of the delta vs. time curve. The Alg-Ox-MA solutions with degrees of oxidation at or 
above 30 failed to form a gel, i.e., photocrosslink, under rheological testing (data not 
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shown). For the other Alg-MA and Alg-Ox-MA solutions and blends, there is a clear 
inflection in the delta curve, indicative of successful photo-initiation and subsequent 
crosslinking. 
G′ is a better indicator for terminal crosslinking as it plateaus. (Figure 99 & 
Figure 1010) Upon inspection of the G′ curves, it appears a majority or crosslinking has 
been completed by 600 s. By this time, G′ has increased by several orders of magnitude 
and the rate of change has decreased substantially. Thus, an exposure time of 10 minutes 
(600 seconds) was used to form hydrogels for burst testing. These behaviors are evident 
in the solutions prepared via the aqueous methacrylation chemistry. Materials with lower 
degrees of methacrylation, i.e. those prepared via anhydrous methacrylation, did not fully 
plateau, although G′ is still orders of magnitude higher, indicating elastic hydrogel 
formation. Rheological values collected past the ten minute point can become unreliable 





Figure 9: Rheological experiments were performed on 3% (w/v) Alg-MA and Alg-MA-Ox solutions 
and (1:1) blends of Alg-MA and Alg-MA-Ox. Top left depicts delta vs. time for Alg-MA, 10 DOO 
Alg-MA-Ox, and 30 DOO Alg-MA-Ox. Top right depicts complex moduli vs. time for Alg-MA,  and 
10 DOO Alg-MA-Ox. Bottom left depicts delta vs. time for (1:1) blends of Alg-MA and Alg-MA-Ox. 
Bottom right depicts complex moduli vs. time for (1:1) blends of Alg-MA and Alg-MA-Ox. Gelation 
time indicated by black arrow. Aqueous methacrylation utilized. 
Figure 10: Rheological experiments were performed on 3% (w/v) Alg-MA, (1:1) blends of Alg-Ox-
MA and Alg-MA, and (1:1) blends of Alg-Ox and Alg-MA. Left depicts delta vs. time.  Right depicts 
complex moduli vs. time. Gelation time indicated by black arrow. Anhydrous methacrylation 
utilized. 
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CHAPTER 5: BURST PRESSURE TESTING 
5.1. Introduction 
Burst pressure values were determined following ASTM F2392-04R10, with 
minor modifications for our photo-crosslinking hydrogel. Data was measured via a 
custom built device designed according to the standard. The main pressure vessel was 
machined from polyether ether ketone (PEEK) to provide low cost fabrication and 
resistance to degradation regardless of the pressurizing fluid. The main vessel measures 
2½ inches in diameter and 17/8 inches in height and is built in two pieces to allow for easy 
specimen loading between the sections. The top section is fastened by means of two ¼”-
20 thread x 1½ inch length bolts permanently fixed in the lower section and held in place 
by two stainless steel thumbscrews. The lower section has a 7/16 inch diameter hole to 
allow fluid from a syringe pump to apply pressure to the substrate, while the top section 
has a 7/8 inch diameter hole, allowing the substrate to react under loading. A 1 inch 
diameter fluoroelastomer o-ring is placed between the sample and top section to provide 
an airtight seal, ensuring that the fluid pressure is applied to the specimen. (Figure 111) 
A syringe pump (Harvard Apparatus PHD 2000 Infusion) was used to pressurize 
the system, which can be used in conjunction with a variety of physiologically relevant 
fluids. A 60 cc, 26.7 mm diameter syringe (ExelInt) was fixed into the syringe pump and 
connected to ¼ inch diameter plastic tubing via a male luer to tube hose adapter. The 
tubing attaches to the pressure vessel via a NPT port bored into the body. A pressure 
transducer (Omega PX-409-030AUSBH) also is connected to the pressure vessel through 
a NPT port, allowing for accurate, real-time data acquisition via a connected computer. 
(Figure 111) Failure mechanism (adhesive or material failure) was assessed via visual 
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inspection of the specimen and a digital microscope (Dino-Lite Pro AM413TA, Dino-
Lite Digital Microscopes) during and after testing. 
 
 
5.2. Liquid Sealant Testing 
 A burst pressure testing protocol was developed and performed utilizing a liquid 
sealant application. All burst pressure tests were conducted at room temperature with 
compressed air at an infusion rate of 75ml/hr. Collagen testing substrates (collagen 
middles natural protein, The Sausage Maker Inc.) were rehydrated for five minutes in 
deionized water. Prior to testing, the substrate is fixed into the burst pressure device and 
pressurized to ensure an intact substrate and proper seal. The substrates were next 
punctured with a 3mm diameter biopsy punch and retested to ensure a through-thickness 
defect was formed. Punctured substrates were clamped between a glass slide and a Teflon 
mold with a 15mm diameter hole centered on the collagen puncture. Hydrogel pre-cursor 
solution (0.5mL) was deposited into the mold, forming a film over the puncture. The 
mold is then placed on a reflective surface, such as aluminum foil, encircled with a 
Figure 11: Schematic illustration of testing setup for mechanical burst pressure testing of alginate-
based sealants. 
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custom, 37/8in diameter LED ring (525nm, NFLS-G30X3-WHT LEDs, 
SuperbrightLEDs), covered with a reflective material, and photocrosslinked for ten 
minutes. 
 After crosslinking, the collagen substrates were unclamped and the Teflon mold 
was carefully removed so as not to disturb the hydrogel sealant. The collagen substrates 
are then removed carefully from the slide to ensure the sealant is not stressed. The 
substrate is positioned in the burst pressure device such that the defect and hydrogel 
sealant are centered in the device. The fluroelastomer o-ring is centered around the 
sealant with no overlapping and top section of the device is clamped in place. The syringe 
pump is enabled and the sealant is tested until failure. Close visual inspection and notes 
of the testing were made in order to determine the mode of failure. Utilization of a digital 
microscope and video recording software greatly enhanced the ability to precisely 
characterize the mode of failure, as the sealant tends to fail in a sudden manner. Figure 
122, below, depicts the modes of failure experienced while testing the liquid sealant. 
  
Figure 12: Cartoon schematic and images of failure modes. 
Intact Sealant Delamination Material Failure 
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 Results from burst pressure testing are shown in Figure 133, with a 
physiologically relevant pulmonary pressure plotted for reference, and summarized in 
Table 1. While the Alg-MA hydrogel withstood the greatest individual pressure, it also 
had the highest standard deviation amongst the groups. In order to understand the burst 
pressure results fully, the mode of failure must be accounted for. Two modes of failure, 
delamination and material, were observed during testing. Delamination occurs when the 
hydrogel patch separates from the substrate with no visible sign of damage. Material 
failure, conversely, occurs when the area directly above the puncture fails, resulting in 
damage to the patch. The Alg-MA patches failed exclusively through delamination, while 
the Alg-MA-Ox patches experienced material failure, with the exception of a single 10 
DOO Alg-MA-Ox:Alg-MA blend trail. Since alginate is inherently non-adhesive, the 
wide variation in burst pressure in Alg-MA could be explained by the mode of failure. 
The Alg-MA-Ox and blended materials are able to adhere to the substrate due to the 
increased substrate interaction resulting from the open-adduct conformation and adhere 
Figure 13: Burst pressure for successful liquid hydrogel sealant (aqueous reaction). Standard error 
mean is depicted. The physiological line represents 30cmH2O, a widely used maximum threshold for 
respiration before pulmonary damage can occur 
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until material failure occurs.  The only case of delamination outside the Alg-MA group 
occurred in the blend with the lowest theoretical degree of oxidation. This lower 
oxidation provides fewer interactions with the substrate, possibly enabling delamination. 
Table 1: Summary of Liquid Sealant Burst Pressure Testing 
Group 











Alg-MA 77 n/a 26.42 ± 12.01 Delamination 
Alg-MA-Ox 70 10 13.96 ± 7.02 Material 
Alg-MA-Ox 
Alg-MA Blend 





70.5 12.5 18.93 ± 5.70 Material 
Alg-MA-Ox 
Alg-MA Blend 
54 19.8 14.79 ± 6.61 Material 
 
 
5.3. Patch Sealant Testing 
 One of the greatest issues with the liquid sealant application is keeping the 
hydrogel in place over the defect during gelation. This problem was overcome in earlier 
testing by using a Teflon mold, but this solution would prove nearly impossible in lung 
tissue applications. Therefore, a solid hydrogel patch was devised to overcome this issue. 
The dry patch could be applied to the lung surface, hydrated with fluids present on the 
tissue surface, and photocrosslinked in situ. 15 DOM, 30 DOM, blended (1:1) 10 DOO 
15 DOM: 15 DOM, blended (1:1) 10 DOO 30 DOM: 30 DOM, blended (1:1) 10 DOO: 
15 DOM, and blended (1:1) 10 DOO: 30 DOM solutions were mixed with 
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photoinitiators to achieve viscous solutions. The resulting solutions were then spun onto 
glass slides and lyophilized to form dry, thin films. The resulting films were removed 
from the slide, punched into 8mm diameter patches, and stored until testing. Once the 
photoinitiator is introduced to the system, all fabrication and handling of the material 
must occur in a dark environment and under red light to prevent gelation from occurring 
prior to application. 
 A new protocol was developed to characterize the burst properties of the 
resulting patches. Burst pressure testing was performed in an environmental incubator 
maintained at 37° C with compressed air at an infusion rate of 75ml/hr. Collagen 
substrates (collagen middles natural protein, The Sausage Maker Inc.) were rehydrated 
for five minutes in deionized water. Prior to testing, the substrate is fixed into the burst 
pressure device and pressurized to ensure an intact substrate and proper seal. The 
substrate was next punctured with a 1.5mm diameter biopsy punch and inspected to 
ensure a through-thickness defect was formed. The substrate surface is placed on a glass 
slide and wetted to allow the patch to begin hydrating upon application. Since the patches 
were thinner than expected, two 8mm diameter patches are placed above the defect and 
wetted with deionized water from an eyedropper. Enough water was applied for the 
patches to become fully hydrated without becoming supersaturated, which could lead to 
disintegration of the patches. The substrate is then covered with the Teflon mold to 
prevent dehydration as a result of close proximity to LEDs during gelation. The glass 
slide is placed on a reflective surface, such as aluminum foil, encircled with a custom, 
37/8in diameter LED ring (525nm, NFLS-G30X3-WHT LEDs, SuperbrightLEDs), 
covered with a reflective material, and photocrosslinked for ten minutes. 
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After crosslinking, the collagen substrates are removed evenly from the slide to 
ensure the sealant is not stressed. The substrate is positioned in the burst pressure device 
such that the defect and hydrogel sealant are centered in the device. The fluroelastomer o-
ring is centered around the sealant with no overlapping and top section of the device is 
clamped in place. The syringe pump is enabled and the sealant is tested until failure. A 
digital microscope and video recording software is used to precisely characterize the 
mode of failure, as the sealant tends to fail in a sudden manner. 
Results from burst pressure tests for the solid application are depicted in Figure 
144 and summarized in Table 2. Both Alg-MA groups saw relatively high burst 
pressures, but also have high deviations. The only blended material with significant burst 
pressures is the 10 DOO:30 DOM blended material. Alg-Ox-MA: Alg-MA (1:1) blends 
experienced very low burst pressures compared to the Alg-MA groups, which suggests 
the material was highly degraded. Oxidation is known to degrade polymer chains and 
alters the conformation of the alginate uronate residue such that the functional 
methacrylate side group is unable to bind. This potentially limited the efficiency of the 
methacrylation reaction and resulted in alginates with lower degrees of methacrylation 
than expected. This lower degree of methacrylation would result in a less crosslinked 
polymer network and ultimately result in a weaker sealant. As was the case with the 
liquid application, methacrylated alginates failed exclusively through delamination, while 
the groups blended with oxidized alginate experienced exclusively material failure before 
delamination could occur. This data also suggests that a simple blend of oxidized and 
methacrylated alginate shows potential as a surgical sealant. Further study of these blends 
will need to be performed to determine the extent of polymer interaction between the two 
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materials and whether separation could occur in time. Since the methacrylation method, 
degree of methacrylation, and order of oxidation and methacrylation all changed between 
the generations of hydrogel sealants, it is not possible to declare either the liquid or dry-
state application method superior at this time. 
 













Alg-MA 15 n/a 51.94 ± 22.94 Delamination 
Alg-MA 30 n/a 52.12 ± 7.42 Delamination 
Alg-Ox-MA 
Alg-MA Blend 
15 5 2.56 ± 0.56 Material 
Alg-Ox-MA 
Alg-MA Blend 
30 5 7.81 ± 5.90 Material 
Alg-Ox Alg-Ma 
Blend 
7.5 5 1.98 ± 0.79 Material 
Alg-Ox Alg Ma 
Blend 
15 5 46.83 ± 11.46 Material 
Figure 14: Burst pressure for solid hydrogel patch sealant. Standard error mean is depicted. Left 
depicted groups with 15 DOM materials. Right depicts groups with 30 DOM materials. 
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CHAPTER 6: EX VIVO LUNG TESTING 
6.1. Introduction 
 Initial mechanical performance of the hydrogel sealants were studied via ex vivo 
mouse lung models. The amount of time and resources going into these ex vivo studies, 
however, was not sustainable for high throughput studies or for developing an optimized 
material. Therefore we transitioned away from the mouse lung model for early iterations 
of materials, instead developing an in-laboratory characterization that allowed for rapid 
testing. While testing on the burst pressure device provides a quick and easy way to 
gather the burst pressure of a hydrogel sealant, the testing conditions do not match 
physiological pulmonary conditions. In order to prove an effective pulmonary sealant, ex 
vivo mouse lung testing must be performed to more closely simulate physiological 
application. Lungs are promptly excised from euthanized mice and cannulated. Once 
excised, the lungs are placed in phosphate buffer solution and mechanically tested on a 
ventilator. Unfortunately, later iterations of the alginate hydrogel sealant were not 
assessed via the mouse lung model. 
6.2 Excision 
 In order to perform successful ex vivo testing, an intact lung must first be 
excised. Mice are euthanized using by lethal administration of sodium pentobarbital 
according to accepted AAALAC and institutional standards and under existing IACUC 
protocol (CHRMS 15-008). The mouse is then stretched and pinned onto a rubber 
surgical mat. An incision is made in the neck and the skin is pulled to the side, exposing 
the neck muscles. These muscles are carefully cut to expose the trachea. An incision is 
made in the trachea so that a cannula can be inserted and tied in place via suture thread. 
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An incision is then made below the ribs and connected to the neck. The skin covering the 
chest can then be pulled to the side, exposing the abdomen and rib cage. Cutting through 
the abdomen and pulling back the liver will expose the diaphragm, which can be 
punctured to deflate the lungs. Next, the ribs and connective tissue lining the lungs is 
removed with care to ensure that the lungs remain intact. After the connective tissue is 
removed, the lungs can be removed from the chest cavity and placed in phosphate buffer 
solution for testing. 
6.3 Mechanical Testing 
 Once excised, the lungs can then be tested on either a Minivent or Flexivent 
ventilator. The Minivent gives the user to ventilate the lungs with control over the tidal 
volume and stroke rate. Lungs are connected to the Minivent via the cannula and 
ventilated to ensure the lung was properly excised with no puncture. Successfully excised 
lungs are then punctured and re-ventilated to confirm a leak as a result of the defect. 
Excised lungs are then sealed with the alginate hydrogel sealant and allowed to crosslink. 
Finally, the lungs are ventilated at 2 cm positive end-expiratory pressure over a range of 
tidal volumes until the sealant fails. The maximum sealant conditions are recorded and 
the tissue and sealant are observed to determine mode of failure. The Flexivent give the 
user the ability to perform more complicated ventilation techniques via a computer 
program. Sensors are also used to measure the volume and pressure during ventilation. 
Lungs tested on the Flexivent are subjected to similar initial testing to validate an 
uninjured lung and subsequently confirm the puncture leak. The results from early ex vivo 
testing on the MiniVent and FlexiVent are summarized below in Table 3 and Table 4, 
respectively. 
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Tidal Volume at Failure 
(μL) 
Failure Mode 
Alg-MA Dry-State 180 325 Delamination 
Alg-MA Dry-State 180 250 Delamination 
Alg-MA Dry-State 180 350 Delamination 
Alg-MA Liquid 180 330 Delamination 
 










 Initial testing on ex vivo mouse lungs indicated that alginate-based hydrogels 
were able to mechanically withstand physiologically relevant conditions before 
delaminating. The repetitive delamination failures showed the need for improved 
adherence to the tissue substrate, which alginate inherently lacks. While both MiniVent 
and FlexiVent testing suggests the alginate hydrogels can serve as pulmonary sealants, all 
sealants delaminated shortly after loading. All methacrylated alginate tested via MiniVent 




Pressure at Failure 
(cmH2O) 
Failure Mode 
Alg-MA Dry-State 25 Delamination 
Alg-MA Dry-State 30 Delamination 
Alg-MA Liquid 25 Delamination 
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CHAPTER 7: CONCLUSIONS 
7.1 Summary of Work 
 Each year thousands of individuals suffer from pleural defects or lung damage 
as a result of trauma, cancer, or various other pulmonary diseases, resulting in fluid flow 
into the pleural cavity. While short term solutions, such as thoracentesis or chest tube 
drainage, are effective at draining the fluid from the pleural cavity, current treatment 
methods for the long-term prevention of recurring leaks is still lacking. Several treatment 
options do exist, but these treatments involve the chemical or physical irritation of the 
pleural lining to inflame the tissue and adhere the two pleurae or synthetic polymer 
sealants in conjunction with conventional methods, such as sutures or staples. Alginate, a  
natural biopolymer derived from brown algae, was investigated as a potential alternative 
tissue sealant for pulmonary surgical applications. Additionally, in-laboratory protocol 
was developed for mechanical characterization of material burst pressure and failure 
analysis. 
Alginate hydrogels were synthesized using high molecular weight, 
commercially available Manugel GMB alginate. The alginate was chemically modified 
via the addition of functional methacrylate side groups onto the polysaccharide backbone, 
i.e. methacrylation, and the exposing of functional aldehyde groups through alteration of 
the alginate uronate structure, i.e. oxidation. Methacrylation of alginate allows for 
covalent crosslinking, which is preferred over the weaker divalent cation ionic 
crosslinking of unmodified alginate. Though unmodified alginate inherently lacks cell-
adhesivity, oxidation enables adhesion through the interaction of the exposed aldehyde 
group and tissue proteins, such as collagen.  Several synthesis methods were utilized, 
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including aqueous and anhydrous methacrylation and sodium periodate oxidation. The 
reaction order was also altered to investigate the hypothesis that oxidation prior to 
methacrylation would result in a more elastic hydrogel. The oxidation reaction, and to a 
lesser extent the anhydrous methacrylation reaction, results in high degrees of polymer 
degradation via chain scission, limiting the application of oxidized methacrylated alginate 
in its purest form. Therefore (1:1) blends of methacrylated alginate and oxidized 
methacrylated alginate or oxidized alginate were studied as well. 
 Rheological testing of the hydrogel precursor solutions indicate that lower 
degrees of oxidation result in less polymer degradation, with an upper limit of 10% 
oxidized alginate indicated from testing. Oxidation before methacrylation degrades the 
polymer, which is then more susceptible to further degradation during the methacrylation 
reaction. Also, oxidation alters the alginate uronate rings, preventing methacrylation from 
occurring as efficiently by eliminating potential binding sites for the methacrylate 
functional group. While the initial hypothesis was that oxidation prior to methacrylation 
might increase elasticity in the hydrogel network, the resulting degradation was too great. 
Methacrylation prior to oxidation will achieve higher degrees of methacrylation and 
lower degrees of degradation prior to oxidation. Low degrees of oxidation will also 
prevent high degrees of degradation while also allowing improved tissue adhesion.  
A burst pressure device was designed, fabricated, and implemented for 
mechanical analysis of various alginate hydrogels and blended solutions. Protocol was 
developed to test both a liquid and solid patch application method, allowing a wider 
range of materials to be analyzed in laboratory. Several hydrogel solutions achieved burst 
pressures of or exceeding relevant physiological pressures and exhibited bulk material 
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failure opposed to not adhesive failure. These results are promising for further analysis of 
visible-light crosslinked alginate-based sealants for pulmonary tissue repair. 
7.2. Future Directions 
 Despite the promise of alginate hydrogels as surgical sealants for pulmonary 
applications, continuing research is needed to develop a sealant for clinical use. Degree 
of methacrylation and oxidation need to be fine-tuned to determine optimized chemical 
modification of alginate for enhanced mechanical sealant properties while obtaining 
effective tissue adhesion. An upper degree of oxidation has been defined in this study, 
therefore lower degrees of oxidation should be investigated for improved adhesion with 
minimal degradation. It is still unclear if lower degrees of methacrylation is superior to 
higher degrees for a surgical sealant application. Hydrogels with higher degrees of 
methacrylation or more densely crosslinked, leading to higher mechanical moduli, but 
also increased stiffness. A successful surgical sealant must balance mechanical strength, 
elasticity, and adhesion. Further investigation into the methacrylation reaction will allow 
for a balance between mechanical strength and elasticity. Lastly, while this research 
focused around the development of an in-laboratory means of mechanically 
characterizing the burst strength and failure mode of hydrogels, ex vivo mouse lung 
model testing must be performed on promising alginate hydrogel systems. In-laboratory 
characterization allows for high throughput, rapid testing of hydrogels to determine 
potentially successful systems, however this characterization method doesn’t simulate the 
complex physiological environment in the pulmonary system. Ex vivo testing more 
closely simulates physiological conditions and will allow for the selection of a final 
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APPENDIX A: Standard Operating Procedures 
A.1 Alginate Partial Oxidation 




 Alginate (FMC BioPolymer) 
 Sodium Periodate, NaIO4 (Sigma Aldrich) 
 Deionised water 
 
Methods: 
1. Prepare 1-2% w/v polymer solution in deionized water 
2. In separate vessel, prepare 2-5% w/v NaIO4 solution in deionized water for 
desired degree of oxidation 
a. Theoretical DOO equivalent to Alginate:NaIO4 ratio 
e.g. 10 DOO 1 g Alginate:0.1g NaIO4 
3. Mix NaIO4 solution into alginate solution and allow to stir for 24 hrs at room 
temperature in dark space 
4. Dialyze against deionized water for 3 days 
5. Freeze at -80°C and lyophilize 
 
Note: Oxidation reaction can be stopped by addition of molar equivalent of ethylene 
glycol to NaIO4 
 
Reference: 
Bouhadir, Kamal H., et al. "Degradation of partially oxidized alginate and its potential 
application for tissue engineering." Biotechnology progress 17.5 (2001): 945-950. 
Jeon, Oju, et al. "The effect of oxidation on the degradation of photocrosslinkable 
alginate hydrogels." Biomaterials 33.13 (2012): 3503-3514. 
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A.2 Burst Pressure Testing- Liquid Application 
 
Goal: To quantify the burst pressure of a liquid hydrogel sealant on a collagen substrate 
utilizing a custom fabricated burst pressure device and to perform failure analysis. 
 
Materials: 
 Hydrogel Precursor Solution and crosslinking system 
 Syringe Pump (Harvard Apparaus PHD 200 Infusion) 
 60 cc syringe (ExelInt, 26.7mm diameter) 
 Burst Pressure Device- BPD (custom fabricated) 
 Pressure Transducer (Omega PX406030AUSBH) 
 Computer or Laptop 
 Digital Microscope (DinoLite Pro AM413TA) 
 Collagen Substrate (Collagen Middles Natural Protein, The Sausage Maker Inc) 
 3mm biopsy punch 
 2x3” glass slide 
 Teflon Mold (2x3” with central 15mm diameter hole) 
 Project clips 
 Deionized water 
 
Methods: 
1) Prepare hydrogel precursor solution to desired concentration 
2) Set up BPD. 
a. Program Harvard Pump to prescribed values: 
i. Syringe: 60cc, 26.7mm diameter 
ii. Infusion Rate: 75ml/hr 
iii. Mode: Volume Infusion 
b. Place syringe on pump 
c. Connect BPD to infusion pump via the luer-lock connector 
i. Ensure an airtight seal. Parafilm can be wrapped around 
connection to help form seal 
d. Connect pressure transducer to BPD via NPT port 
i. Ensure airtight seal. Teflon tape can be used in threading to help 
form seal 
e. Connect pressure transducer to laptop and open up data acquisition 
software 
i. Sampling rate can be adjusted to your desire, but 10Hz seems 
suitable 
ii. Adjust units accordingly. inH2O is useful for surgical sealant 
applications as there is no cmH2O setting 
3) Prepare collagen substrates 
a. Cut collagen to form 3cm squares 
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b. Just prior to testing, rehydrate in deionized water for 5 minutes 
4) Ensure the system is airtight and the collagen substrate is intact by testing 
unpunctured substrate in BPD 
a. Place collagen over hole in lower half of BPD 
b. Place o-ring over collagen substrate 
c. Place top half of BPD over substrate and O-ring 
d. Connect two halves with two hand screws 
e. Begin data acquisition software and engage syringe pump 
f. After confirming pressure is building in system (via acquisition software), 
disengage syringe pump and data acquisition and remove substrate from 
BPD 
5) Punch 3mm hole in center of collagen substrate 
a. Confirm through thickness defect via testing on BPD or visual inspection 
6) Clamp substrate between glass slide and Teflon mold such that puncture defect is 
centered in the mold 
7) Pour 0.5mL of hydrogel precursor solution into Teflon mold and crosslink in 
place 
a. Previous studies should be performed to determine necessary form and 
duration of crosslinking 
8) Unclamp mold and carefully remove Teflon top to minimize stress to sealant 
9) Slide collagen substrate from glass slide to BPD to minimize stress to the sealant 
10) Fix substrate into BDP so that puncture and sealant are centered 
11) Place digital microscope over BPD and connect to computer 
12) Begin video and data acquisition and engage pump 
a. Allow pressure to build in device until failure (sealant is broken and 
unable to withstand pressure) 
13) Disengage syringe pump and data/video acquisition 
a. Save data file as excel to recreate pressure curves 
b. Video can be viewed to determine mode of failure 
i. Delamination- sealant separates from substrate with no visible 
damage 
ii. Material Failure- patch fails directly above puncture but remains 
adhered 
14) Remove sample from BPD for examination and disposal 
 
Note: This test can be performed on laboratory benchtop at room temperature or can be 




ASTM F2392-04(2015), Standard Test Method for Burst Strength of Surgical Sealants, 
ASTM International, West Conshohocken, PA, 2015, www.astm.org 
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A.3 Burst Pressure Testing- Dry State Application 
 
Goals: To quantify the burst pressure of a dry-state hydrogel sealant on a collagen 




 Hydrogel Precursor Patch and crosslinking system 
 Syringe Pump (Harvard Apparaus PHD 200 Infusion) 
 60 cc syringe (ExelInt, 26.7mm diameter) 
 Burst Pressure Device- BPD (custom fabricated) 
 Pressure Transducer (Omega PX406030AUSBH) 
 Computer or Laptop 
 Digital Microscope (DinoLite Pro AM413TA) 
 Collagen Substrate (Collagen Middles Natural Protein, The Sausage Maker Inc) 
 8mm Biopsy Punch 
 1.5mm Biopsy Punch 
 2x3” Glass Slide 
 Teflon Mold (2x3” with central 15mm diameter hole) 
 Mist Bottle 
 Eye Dropper 
 Deionized Water 
 
Methods: 
1. Punch prepared hydrogel precursor patch using 8mm biopsy punch 
2. Set up BPD. 
a. Program Harvard Pump to prescribed values: 
i. Syringe: 60cc, 26.7mm diameter 
ii. Infusion Rate: 75ml/hr 
iii. Mode: Volume Infusion 
b. Place syringe on pump 
c. Connect BPD to infusion pump via the luer-lock connector 
i. Ensure an airtight seal. Parafilm can be wrapped around 
connection to help form seal 
d. Connect pressure transducer to BPD via NPT port 
i. Ensure airtight seal. Teflon tape can be used in threading to help 
form seal 
e. Connect pressure transducer to laptop and open up data acquisition 
software 
i. Sampling rate can be adjusted to your desire, but 10Hz seems 
suitable 
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ii. Adjust units accordingly. inH2O is useful for surgical sealant 
applications as there is no cmH2O setting 
3. Prepare collagen substrates 
a. Cut collagen to form 3cm squares 
b. Just prior to testing, rehydrate in deionized water for 5 minutes 
4. Ensure the system is airtight and the collagen substrate is intact by testing 
unpunctured substrate in BPD 
a. Place collagen over hole in lower half of BPD 
b. Place o-ring over collagen substrate 
c. Place top half of BPD over substrate and O-ring 
d. Connect two halves with two hand screws 
e. Begin data acquisition software and engage syringe pump 
f. After confirming pressure is building in system (via acquisition software), 
disengage syringe pump and data acquisition and remove substrate from 
BPD 
5. Punch 1.5mm hole in center of collagen substrate 
a. Confirm through thickness defect via testing on BPD or visual inspection 
6. Lightly wet (mist bottle) collagen surface and place on glass slide 
7. Apply 2 patches over defect and rehydrate with deionized water using eye dropper 
a. Lightly apply pressure to patch to ensure solid contact with substrate 
without damaging patch, which can be brittle and subject to cracking  
b. Do not supersaturate hydrogel to avoid dissolution/dissolving 
c. 1-2 drops of water per patch seems to suffice, but this amount should be 
adjusted for patch thickness, composition, etc. 
8. Cover remainder of substrate with Teflon mold to help prevent dehydration of 
substrate during crosslinking 
9. Crosslink patch in place 
a. Previous studies should be performed to determine necessary form and 
duration of crosslinking 
b. Remove Teflon mold after crosslinking 
10. Slide collagen substrate from glass slide to BPD to minimize stress to the sealant 
11. Fix substrate into BDP so that puncture and sealant are centered 
12. Place digital microscope over BPD and connect to computer 
13. Begin video and data acquisition and engage pump 
a. Allow pressure to build in device until failure (sealant is broken and 
unable to withstand pressure) 
14. Disengage syringe pump and data/video acquisition 
a. Save data file as excel to recreate pressure curves 
b. Video can be viewed to determine mode of failure 
i. Delamination- sealant separates from substrate with no visible 
damage 
ii. Material Failure- patch fails directly above puncture but remains 
adhered 
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15. Remove sample from BPD for examination and disposal 
 
Note: This test can be performed on laboratory benchtop at room temperature or can be 




ASTM F2392-04(2015), Standard Test Method for Burst Strength of Surgical Sealants, 
ASTM International, West Conshohocken, PA, 2015, www.astm.org 
 
